Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability欧洲生物制药产品的引入:早期扩散模式与数据可用性的横断面研究BioDrugsIF6.92025-08-080OAAI
Prescribing beyond borders: Navigating challenges and opportunities in cross-border ePrescriptions for enhanced medication access and safetyRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82025-03-010PRE
Implementation of European Cross-border Electronic Prescription and Electronic Dispensing Service: Cross-sectional SurveyJOURNAL OF MEDICAL INTERNET RESEARCHIF62023-04-043OA
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the FutureFRONTIERS IN PUBLIC HEALTHIF3.42021-06-2428OAAI
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsFRONTIERS IN PUBLIC HEALTHIF3.42018-12-05119OAAI
Use of a national database as a tool to identify primary medication non-adherence: The Estonian ePrescription systemRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82018-08-018PREAI
Adherence to osteoporosis medicines in Estonia-a comprehensive 15-year retrospective prescriptions database studyARCHIVES OF OSTEOPOROSISIF2.82017-06-226PREAI
Trends in and relation between hip fracture incidence and osteoporosis medication utilization and prices in Estonia in 2004-2015ARCHIVES OF OSTEOPOROSISIF2.82017-05-116PREAI